RNA, 7SL, cytoplasmic 265, pseudogene (RN7SL265P)

RN7SL265P encodes a non-functional, non-coding RNA sequence that is homologous to the 7SL RNA component of the signal recognition particle (SRP)[6][1][5]. The 7SL RNA itself is a highly conserved small cytoplasmic RNA that forms the core of the SRP, which is essential for directing the cellular localization of newly synthesized proteins[3][7]. However, the majority of 7SL-like loci found in the genome—including RN7SL265P—are pseudogenes: DNA sequences that arose through retrotransposition or genomic rearrangement and are not expressed as functional RNA or protein[1][5][6][2]. These pseudogenes usually lack promoter elements or accumulate disabling mutations[2][1]. While some pseudogenes can regulate gene expression or act as competitive endogenous RNAs, there is no current evidence that RN7SL265P performs such a function or has clinical significance[6][4]. No known disease association, biomarker use, or drug interaction is documented for this locus. RN7SL265P is not a therapeutic target (such as a receptor, enzyme, transporter, or transcription factor); it is a pseudogene[6][1][5]. The designation is scientifically correct: it refers to a particular locus of a 7SL RNA-related pseudogene; not misspelled or inaccurate, but not a functional gene. No reported clinical utility or pharmacological relevance; it is not known to interact with drugs, nor implicated in disease, nor used as a biomarker. If further context is needed regarding the 7SL RNA (functional version), the canonical molecule has architectural and regulatory roles in SRP function and protein targeting, but the pseudogene variants like RN7SL265P do not possess these biological roles[3][7][1].

Other names

RN7SL265P